Transcatheter aortic valve implantation (TAVI) and thoracic endovascular aortic repair (TEVAR) are independently well established techniques for treating aortic valve stenosis and thoracic aortic aneurysms. The co-existence of both lesions in patients occurs as they share similar risk factors but the treatment of patients with these combined lesions and high surgical risk remains unclear. The presence of a thoracic aneurysm was an exclusion criterion in the landmark PARTNER trial. The presence of such a lesion increases the risks of aortic rupture and significant device interaction may occur during the procedure. There have thus been no prior reports of the feasibility of treating such patients with combined TAVI and TEVAR.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.